Please enable Javascript to use all features and improve your user experience.
ST Herbst 2022 der DGNC
Programme
People
Search
EN
All people
Daniel Delev
Sort by Type
Date
Further involvements
28/10/2022
11:55
–
12:05
7 Min.
3 Min.
Abstractvortrag
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy – the MecMeth/NOA-24 trial study protocol
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy